Concepedia

Laura Cove-Smith

LC

9

Publications

378

Citations

9

H-Index

2014

Active since

Affiliations

University of Manchester(Current)

The Christie NHS Foundation Trust

South Tees Hospitals NHS Foundation Trust

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Hôpital Intercommunal de Créteil

Laura Cove-Smith is an author at University of Manchester specializing in medicine, oncology, and pathology.

Top concepts

Publications per year

2014–2025

9

Publications

9

Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial

Marina Chiara Garassino, Julien Mazières, Martin Reck et al. · Journal of Thoracic Oncology · 2022 · 112 citations · Full text

Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial

Eric Lim, David Waller, Kelvin Lau et al. · The Lancet Respiratory Medicine · 2024 · 99 citations · Full text

An Integrated Characterization of Serological, Pathological, and Functional Events in Doxorubicin-Induced Cardiotoxicity

Laura Cove-Smith, Neil Woodhouse, Adam Hargreaves et al. · Toxicological Sciences · 2014 · 57 citations

, , +23

Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma

Liezel Griffin, Laura Cove-Smith, Hana Alachkar et al. · JAAD Case Reports · 2018 · 49 citations · Full text

Real-World Data on Pembrolizumab for Pretreated Non-Small-Cell Lung Cancer: Clinical Outcome and Relevance of the Lung Immune Prognostic Index

Ana Ortega-Franco, Clare Hodgson, H Raja et al. · Targeted Oncology · 2022 · 13 citations

, , +10

Rows per page

1–5 of 9